[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Page 15672]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06007]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-IP-21-003, Collaborative Research on 
Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory 
Pathogens in South Africa; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-IP-21-003, Collaborative Research on Influenza, Coronavirus 
Disease 2019 (COVID-19), and Other Respiratory Pathogens in South 
Africa; May 13, 2021, 10 a.m.-5 p.m., EDT, Teleconference, Centers for 
Disease Control and Prevention, Room 1080, 8 Corporate Square 
Boulevard, Atlanta, Georgia 30329-4027. The meeting was published in 
the Federal Register on January 11, 2021, Volume 86, Number 6, pages 
1976-1977.
    The meeting is being amended to change the title and meeting dates 
of the special emphasis panel from RFA-IP-21-003, Collaborative 
Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other 
Respiratory Pathogens in South Africa; May 13, 2021, 10 a.m.-5 p.m., 
EDT to RFA-IP-21-002, US Enhanced Surveillance Network to Assess 
Burden, Natural History, and Effectiveness of Vaccines to Prevent 
Enteric and Respiratory Viruses in Children; May 4-5, 2021, 10 a.m.-5 
p.m., EDT. The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027, (404) 718-8833, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-06007 Filed 3-23-21; 8:45 am]
BILLING CODE 4163-18-P